Robust IPO activity through the remainder of 2026 underpins trader expectations for multiple listings before year-end. The U.S. market has seen a strong recovery, with over 70 traditional deals completed by mid-year and dozens more in the active pipeline, including sizable September offerings such as Holtec Nuclear (targeting ~$825 million) and Orion180 Insurance. Recent filings from smaller issuers and SPACs, alongside continued momentum in AI-adjacent and energy sectors, reflect supportive equity valuations and manageable interest-rate conditions. Key near-term catalysts include scheduled pricings in mid-to-late September and October, while delays among mega-cap names like OpenAI to 2027 do not alter the broader calendar of smaller and mid-sized transactions expected to resolve the market well before January 2027.

Sep 8 2026

Mistral AI closes €3 billion funding round at €21 billion valuation

Mistral AI completed a €3 billion Series D funding round in September 2026, raising its valuation to approximately €21 billion (~$24 billion). The company confirmed IPO remains a long-term possibility but no immediate plans or filings have been made.

Sep 8 2026

Mistral AI completes €3 billion Series D funding at €21 billion valuation

Mistral AI announced completion of a €3 billion Series D funding round on September 8, 2026, raising its valuation to over €21 billion. The company stated an IPO remains an option but has no scheduled date, focusing on growth and infrastructure expansion.

Show more